Mounjaro is FDA-approved for type 2 diabetes but prescribed off-label for weight loss
In some clinical trials, there have also been some side effects reported
At JosephCareRX, we prioritize patient safety and encourage open discussions about the potential side effects, such as gastrointestinal discomfort, which typically subside as the body adapts to the treatment
Semaglutide, GLP-1 Drugs, and IBS: Managing Side Effects and Gut Health Aleks Jagiello BSc, MSc, RD Sep 11, 2025 17 min read Glucagon-like peptide-1 (GLP-1) receptor agonist medications, such as semaglutide (brand names Wegovy, Ozempic ), have surged in popularity for weight loss and type 2 diabetes management